Cantor Fitzgerald, L. P. Tiziana Life Sciences LTD Transaction History
Cantor Fitzgerald, L. P.
- $2.48 Billion
- Q4 2024
A detailed history of Cantor Fitzgerald, L. P. transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 11,491 shares of TLSA stock, worth $10,571. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,491
Previous 12,091
4.96%
Holding current value
$10,571
Previous $11,000
36.36%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TLSA
# of Institutions
32Shares Held
993KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA246KShares$226,0640.0% of portfolio
-
Morgan Stanley New York, NY111KShares$101,9640.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$96,9350.0% of portfolio
-
Zhang Financial LLC93.2KShares$85,7320.0% of portfolio
-
Kovitz Investment Group Partners, LLC79.4KShares$73,0150.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $94.1M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...